Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 273,700 shares, a growth of 38.0% from the August 31st total of 198,300 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average daily volume of 4,630,000 shares, the short-interest ratio is currently 0.1 days.
Autonomix Medical Stock Up 2.4 %
Shares of NASDAQ AMIX traded up $0.01 during mid-day trading on Friday, reaching $0.60. 31,618 shares of the company were exchanged, compared to its average volume of 1,849,576. Autonomix Medical has a 1 year low of $0.51 and a 1 year high of $7.60. The firm has a 50-day moving average of $0.79 and a 200 day moving average of $1.73. The company has a current ratio of 9.27, a quick ratio of 9.27 and a debt-to-equity ratio of 0.20.
Autonomix Medical (NASDAQ:AMIX – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.14) earnings per share for the quarter. On average, equities analysts predict that Autonomix Medical will post -0.5 EPS for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Stock Analysis on AMIX
Autonomix Medical Company Profile
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Featured Articles
- Five stocks we like better than Autonomix Medical
- Why Are Stock Sectors Important to Successful Investing?
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Upcoming IPO Stock Lockup Period, Explained
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
- What is a Dividend King?
- What Intuitive Machines’ Big NASA Contract Means for Investors
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.